Alvotech, a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, has appointed Sarah Tanksley to its corporate leadership team as Chief Quality Officer, effective October 14. Tanksley succeeds Reem Malki, who is stepping down for personal reasons.   “Sarah has been actively working with Alvotech as a consultant and we are very pleased that she will join our team in this new capacity,” said Mark Levick, chief executive officer of...